Business process description for committee management
Submitted by Anonymous (not verified) on 22 April 2025 - 15:07
Business process description for committee management
Template for late submission of ICSRs to EV
Submitted by Anonymous (not verified) on 22 April 2025 - 14:48
Template for late submission of ICSRs to EV
European Medicines Agency’s data protection notice for EudraVigilance Human (EV)
Submitted by Anonymous (not verified) on 22 April 2025 - 14:40
European Medicines Agency’s data protection notice for EudraVigilance Human (EV)
Qualification opinion for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology in liver biopsies to determine disease activity in NASH/MASH clinical trials
Submitted by Anonymous (not verified) on 22 April 2025 - 14:03
Qualification opinion for artificial intelligence-based measurement of non-alcoholic steatohepatitis histology in liver biopsies to determine disease activity in NASH/MASH clinical trials
PSUSA/00002774/202408
Submitted by Anonymous (not verified) on 16 April 2025 - 16:15
PSUSA/00002774/202408
PSUSA/00000027/202407
Submitted by Anonymous (not verified) on 16 April 2025 - 16:14
PSUSA/00000027/202407
Variations requiring assessment (veterinary medicines)
Submitted by Anonymous (not verified) on 16 April 2025 - 15:35
Variations requiring assessment (veterinary medicines)
Human medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 26, Status: Authorised
Submitted by Anonymous (not verified) on 16 April 2025 - 15:05
Human medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 26, Status: Authorised
EMA Agile governance model
Submitted by Anonymous (not verified) on 16 April 2025 - 12:32
EMA Agile governance model
Medicinal products for human use: monthly figures - March 2025
Submitted by Anonymous (not verified) on 16 April 2025 - 12:28
Medicinal products for human use: monthly figures - March 2025